Physician profile
Ruby Parikh
NPI 1558781401
$583.95
in general payments reported to CMS, 2019-2025
11 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $261 · 2023: $22.21 · 2024: $173 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $323.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $171.45 | 2022-2025 | Clareon, Rocklatan, Clareon Panoptix Pro |
| Rxsight INC | $151.13 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $48.47 | 2024 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $45.15 | 2022 | |
| Abbvie INC. | $30.04 | 2024 | |
| Glaukos Corporation | $29.50 | 2025 | Idosetr |
| Bausch & Lomb Americas INC. | $24.76 | 2024 | Miebo |
| Thea Pharma INC. | $23.84 | 2024 | Iyuzeh |
| Sight Sciences, INC. | $20.60 | 2024 | Omni Surgical System |
| Harrow Eye, LLC | $20.51 | 2025 | Vevye |
| Oyster Point Pharma, INC. | $18.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruby Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.